XML 54 R43.htm IDEA: XBRL DOCUMENT v3.25.3
Supplemental Financial Information - Accounts Payable and Accrued Liabilities (Details) - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Other Balance Sheet Details [Abstract]    
Sales rebates and reserves $ 237.9 $ 144.2
Accrued employee related costs 105.1 107.5
Accrued development costs 82.4 50.8
Current branded prescription drug fee 39.0 49.2
Accounts payable and other accrued liabilities 119.9 109.9
Total accounts payable and accrued liabilities $ 584.3 $ 461.6